CompletedPhase 3

Comprehensive Add on Study in Japan

NCT01204294

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

1218.78.008 Boehringer Ingelheim Investigational Site

Akishima, Tokyo, Japan

+42 additional locations

View on ClinicalTrials.gov

Save this trial

Quick facts

Start date: 2010-09
Enrollment: 574 participants
Sponsor: Boehringer Ingelheim
Purpose: treatment

Locations (43)

1218.78.008 Boehringer Ingelheim Investigational SiteAkishima, Tokyo, Japan
1218.78.030 Boehringer Ingelheim Investigational SiteAmagasaki, Hyogo, Japan
1218.78.017 Boehringer Ingelheim Investigational SiteAnnaka, Gunma, Japan
1218.78.006 Boehringer Ingelheim Investigational SiteAomori, Aomori, Japan
1218.78.007 Boehringer Ingelheim Investigational SiteAomori, Aomori, Japan
1218.78.009 Boehringer Ingelheim Investigational SiteChuo-ku, Tokyo, Japan
1218.78.013 Boehringer Ingelheim Investigational SiteChuo-ku, Tokyo, Japan
1218.78.032 Boehringer Ingelheim Investigational SiteFukuoka, Fukuoka, Japan
1218.78.040 Boehringer Ingelheim Investigational SiteFukuoka, Fukuoka, Japan
1218.78.037 Boehringer Ingelheim Investigational SiteHigashi Osaka, Osaka, Japan
1218.78.043 Boehringer Ingelheim Investigational SiteHitachinaka, Ibaraki, Japan
1218.78.019 Boehringer Ingelheim Investigational SiteIsesaki, Gunma, Japan
1218.78.036 Boehringer Ingelheim Investigational SiteKashiwara, Osaka, Japan
1218.78.026 Boehringer Ingelheim Investigational SiteKasugai, Aichi, Japan
1218.78.038 Boehringer Ingelheim Investigational SiteKawachinagano, Osaka, Japan
1218.78.021 Boehringer Ingelheim Investigational SiteKitaazumi-gun, Nagano, Japan
1218.78.022 Boehringer Ingelheim Investigational SiteMatsumoto, Nagano, Japan
1218.78.033 Boehringer Ingelheim Investigational SiteMatsumoto, Nagano, Japan
1218.78.012 Boehringer Ingelheim Investigational SiteMeguro-ku, Tokyo, Japan
1218.78.041 Boehringer Ingelheim Investigational SiteMeguro-ku, Tokyo, Japan
1218.78.034 Boehringer Ingelheim Investigational SiteMorioka, Iwate, Japan
1218.78.035 Boehringer Ingelheim Investigational SiteMorioka, Iwate, Japan
1218.78.018 Boehringer Ingelheim Investigational SiteMoriya, Ibaraki, Japan
1218.78.024 Boehringer Ingelheim Investigational SiteNagoya, Aichi, Japan
1218.78.025 Boehringer Ingelheim Investigational SiteNagoya, Aichi, Japan
1218.78.027 Boehringer Ingelheim Investigational SiteNagoya, Aichi, Japan
1218.78.028 Boehringer Ingelheim Investigational SiteNagoya, Aichi, Japan
1218.78.031 Boehringer Ingelheim Investigational SiteNagoya, Aichi, Japan
1218.78.039 Boehringer Ingelheim Investigational SiteOita, Oita, Japan
1218.78.004 Boehringer Ingelheim Investigational SiteOkinawa, Okinawa, Japan
1218.78.016 Boehringer Ingelheim Investigational SiteSagae, Yamagata, Japan
1218.78.001 Boehringer Ingelheim Investigational SiteSapporo, Hokkaido, Japan
1218.78.020 Boehringer Ingelheim Investigational SiteSapporo, Hokkaido, Japan
1218.78.042 Boehringer Ingelheim Investigational SiteSapporo, Hokkaido, Japan
1218.78.005 Boehringer Ingelheim Investigational SiteShimajiri-gun, Okinawa, Japan
1218.78.014 Boehringer Ingelheim Investigational SiteShinjuku-ku, Tokyo, Japan
1218.78.002 Boehringer Ingelheim Investigational SiteShinjyuku-ku. Tokyo, Japan
1218.78.011 Boehringer Ingelheim Investigational SiteShizuoka, Shizuoka, Japan
1218.78.003 Boehringer Ingelheim Investigational SiteSuita, Osaka, Japan
1218.78.023 Boehringer Ingelheim Investigational SiteTokorozawa, Saitama, Japan
1218.78.029 Boehringer Ingelheim Investigational SiteTokorozawa, Saitama, Japan
1218.78.010 Boehringer Ingelheim Investigational SiteTsuchiura, Ibaraki, Japan
1218.78.015 Boehringer Ingelheim Investigational SiteYamagata, Yamagata, Japan